PSYCHEDELICS TO DEBUT ON NASDAQ

In a big milestone for the nascent psychedelics industry, Peter Thiel-backed  pharmaceutical company Compass Pathways, filed to go public on the NASDAQ.
BNN Bloomberg

• It plans to use the proceeds to fund clinical trials for psilocybin as a treatment for depression.